acetylglucosamine has been researched along with Shock, Septic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bertrand, L; Betus, C; Bigot-Corbel, E; Bultot, L; Denis, M; Dhot, J; Dontaine, J; Dupas, T; Erraud, A; Lauzier, B; Lebreton, J; Leroux, AA; Maillard, A; Montnach, J; Pelé, T; Persello, A; Rivière, M; Rozec, B; Tessier, A; Vertommen, D; Waard, M | 1 |
Aillerie, V; Bigot, E; Cadiet, J; Chatham, JC; Denis, M; Erraud, A; Ferron, M; Gauthier, C; Lauzier, B; Mevel, M; Persello, A; Prat, V; Rozec, B | 1 |
2 other study(ies) available for acetylglucosamine and Shock, Septic
Article | Year |
---|---|
An
Topics: Acetylation; Acetylglucosamine; Animals; ATP Citrate (pro-S)-Lyase; Fluid Therapy; Lipopolysaccharides; Protein Processing, Post-Translational; Rats; Shock, Septic | 2021 |
O-GlcNAc stimulation: A new metabolic approach to treat septic shock.
Topics: Acetylglucosamine; Animals; beta-N-Acetylhexosaminidases; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Fluid Therapy; Humans; Lipopolysaccharides; Male; Protein Processing, Post-Translational; Rats; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Shock, Septic | 2019 |